Acer Therapeutics Inc. (ACER): Price and Financial Metrics
ACER Price/Volume Stats
| Current price | $0.66 | 52-week high | $4.56 |
| Prev. close | $0.80 | 52-week low | $0.55 |
| Day low | $0.66 | Volume | 574,600 |
| Day high | $0.85 | Avg. volume | 885,392 |
| 50-day MA | $0.81 | Dividend yield | N/A |
| 200-day MA | $1.00 | Market Cap | 16.15M |
ACER Stock Price Chart Interactive Chart >
Acer Therapeutics Inc. (ACER) Company Bio
Acer Therapeutics Inc., formerly Opexa Therapeutics, develops therapies for the treatment of serious ultra-rare diseases with critical unmet medical needs. The company offers Celiprolol for vascular ehlers-danlos syndrome and ACER-001 for maple syrup urine disease. It also offers advancing ACER-001 for the treatment of urea cycle disorders. The company was founded in 2013 and is based in Cambridge, Massachusetts.
ACER Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -70.54% |
| 5-year | -80.47% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | 10.09% |
| 2021 | -12.98% |
| 2020 | -34.66% |
| 2019 | -80.07% |
Loading social stream, please wait...